Suchergebnisse - "Vaduganathan, Muthiah"

PubPharm (56)

1

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction : An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials

enthalten in: Journal of the American Heart Association | 2024

von Bhatt, A. | Vaduganathan, M. | Claggett, B. | +13

2

Reply : Rethinking eGFR Comparisons in SGLT2 Inhibitor Research

enthalten in: Journal of the American College of Cardiology | 2024

von Chatur, S. | Vaduganathan, M. | Claggett, B. | +1

3

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

enthalten in: Circulation | 2024

von Neuen, B. | Heerspink, H. | Vart, P. | +13

4

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction : A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial

enthalten in: JAMA cardiology | 2024

von Mc Causland, F. | Claggett, B. | Vaduganathan, M. | +19

5

Chapter 2 : Clinical and Mechanistic Potential of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors in Heart Failure with Preserved Ejection Fraction

enthalten in: The American journal of medicine | 2024

von Ostrominski, J. | Vaduganathan, M.

6

SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction

enthalten in: JACC. Heart failure | 2024

von Avula, V. | Sharma, G. | Kosiborod, M. | +16

7

Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade : A Joint Analysis of the CREDENCE and DAPA-CKD Trials

enthalten in: Journal of the American Society of Nephrology : JASN | 2023

von Fletcher, R. | Jongs, N. | Chertow, G. | +13

8

Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease : A joint analysis of randomized controlled clinical trials

enthalten in: Diabetes, obesity & metabolism | 2023

von Heerspink, H. | Vart, P. | Jongs, N. | +10

9

Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure

enthalten in: Journal of the American College of Cardiology | 2023

von Kondo, T. | Wang, X. | Yang, M. | +19

10

Potential global impact of sodium-glucose cotransporter-2 inhibitors in heart failure

enthalten in: European journal of heart failure | 2023

von Talha, K. | Butler, J. | Greene, S. | +9

CommentIn: Eur J Heart Fail. 2023 Jul;25(7):1010-1011. - PMID 37218602

1
2
3
4
5
6
Nächster »
[6]